Detecting Clinically Significant Prostate Cancer With Advanced MRI Protocols and Extensive Histopathology
Recruiting
Observational Study
Prostate Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Male
- Study type
- Observational
- Participants needed
- 300 (estimated)
- Sponsor
- Virdx, Inc. · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
In recent years, new and promising approaches have emerged in the field of MRI imaging of the prostate. These approaches usually aim to visualise the so-called "microstructures" of the tissue and are intended to offer greater accuracy in the diagnosis of prostate cancer than the current mpMRI examination. To this end, mathematical microstructure models are calculated that determine the proportiona…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Humans with a prostate ≥18 years of age.
* Patients with biopsy-proven PCa who are scheduled for an RPE.
* Signed informed consent form (ICF) that demonstrates study participant understands the purpose of and procedures necessary for the study.
* Willingness, ability, and lega…
Contacts